Crunching the numbers for KZR... Refresh in a moment for the full analysis.
Kezar Life Sciences, Inc. (KZR)
mixed
$7.37
Updated: 2026-04-13
56
TradeApes Score
hold
Financial Strength
55
Mixed
Operating Trend
50
Mixed
Valuation
50
Mixed
Capital Allocation
60
Healthy
Risk
80
Strong
Key Findings
+
Strong FCF growth — free cash flow up more than 20% year over year
−
Negative ROIC — business destroying value on invested capital
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Add to Watchlist
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.